VMVAX | VVOAX | VMVAX / VVOAX | |
Total Expense Ratio | 0.07 | 1.07 | 7% |
Annual Report Gross Expense Ratio | 0.07 | 1.07 | 7% |
Fund Existence | 14 years | 24 years | - |
Gain YTD | 5.532 | 4.802 | 115% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 3000 | 1000 | 300% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 30.6B | 5.21B | 588% |
Annual Yield % from dividends | 2.26 | 0.38 | 598% |
Returns for 1 year | 9.76 | 11.92 | 82% |
Returns for 3 years | 28.18 | 44.63 | 63% |
Returns for 5 years | 71.82 | 119.52 | 60% |
Returns for 10 years | 93.07 | 59.46 | 157% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PAGRX | 126.14 | 0.98 | +0.78% |
Permanent Portfolio Aggressive Growth I | |||
GEIZX | 17.88 | 0.08 | +0.45% |
GuideStone Funds Growth Equity Index Inv | |||
AULRX | 84.26 | 0.35 | +0.42% |
American Century Ultra® R | |||
MRRFX | 17.43 | 0.03 | +0.17% |
BlackRock Mid-Cap Value R | |||
JHTAX | 19.90 | 0.02 | +0.10% |
JPMorgan Hedged Equity 3 A |